Corrigendum to “Efficacy of rituximab as second-line therapy for autoimmune encephalitis: A systematic review and meta-analysis” [Volume 11, Issue 2, 30 January 2025, e41747]

Read full text Summarise with VIRAT
Authors: Lin-Ming Zhang, Xuan-lin Xing, Bing-ran Zhang, Qiu-Juan Zhang, Yanlin Zhu, Shu-ji Gao, Ming-wei Liu
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In this article, the authors have included two duplications in the reference list; references 7,49 and 10, 43 are found to be the same. The authors confirm that the duplications were introduced in the article due to an inadvertent error and duplicated references 7 and 10 to be replaced.

Fields of Study & Subjects

Autoimmune Neurological Disorders and Treatments Autoimmune Bullous Skin Diseases Peripheral Neuropathies and Disorders

Publication details

Journal / source
Heliyon
Volume
12
Issue
5
Pages
e44799–e44799
Publication date
1 March 2026
Language
EN